US · Healthcare

Oasmia Pharmaceutical AB (OASMY)

Drug Manufacturers - Specialty & Generic

Oasmia Pharmaceutical AB (OASMY) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for OASMY

P/E ratio
18.00

Oasmia Pharmaceutical AB (OASMY) — FAQ

What is OASMY's P/E ratio?

The price-to-earnings (P/E) ratio for Oasmia Pharmaceutical AB (OASMY) is 18.00 (data as of 2026-03-24).

Does Oasmia Pharmaceutical AB pay a dividend?

Dividend yield is not available in the current snapshot for Oasmia Pharmaceutical AB (OASMY). Check the MyAverix Finance app for the latest dividend data.

What sector is Oasmia Pharmaceutical AB in?

Oasmia Pharmaceutical AB (OASMY) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is OASMY listed on?

OASMY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play